Abstract
Concomitant radiotherapy and superselective arterial infusion of cisplatin for laryngeal cancer has shown excellent therapeutic outcomes. It is expected to be a reasonable treatment option for laryngeal cancer, especially in locally advanced cases.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use*
-
Cisplatin / administration & dosage
-
Cisplatin / therapeutic use*
-
Combined Modality Therapy
-
Female
-
Follow-Up Studies
-
Humans
-
Infusions, Intra-Arterial
-
Laryngeal Neoplasms / drug therapy*
-
Laryngeal Neoplasms / pathology
-
Laryngeal Neoplasms / radiotherapy*
-
Male
-
Middle Aged
-
Survival Analysis
Substances
-
Antineoplastic Agents
-
Cisplatin